Changes in clot lysis levels of reteplase and streptokinase following continuous wave ultrasound exposure, at ultrasound intensities following attenuation from the skull bone

<p>Abstract</p> <p>Background</p> <p>Ultrasound (US) has been used to enhance thrombolytic therapy in the treatment of stroke. Considerable attenuation of US intensity is however noted if US is applied over the temporal bone. The aim of this study was therefore to explo...

Full description

Bibliographic Details
Main Authors: Roijer Anders, Carlson Jonas, Härdig Bjarne
Format: Article
Language:English
Published: BMC 2008-08-01
Series:BMC Cardiovascular Disorders
Online Access:http://www.biomedcentral.com/1471-2261/8/19
id doaj-023502a7194c4af8a304d74877b7570b
record_format Article
spelling doaj-023502a7194c4af8a304d74877b7570b2020-11-25T03:13:34ZengBMCBMC Cardiovascular Disorders1471-22612008-08-01811910.1186/1471-2261-8-19Changes in clot lysis levels of reteplase and streptokinase following continuous wave ultrasound exposure, at ultrasound intensities following attenuation from the skull boneRoijer AndersCarlson JonasHärdig Bjarne<p>Abstract</p> <p>Background</p> <p>Ultrasound (US) has been used to enhance thrombolytic therapy in the treatment of stroke. Considerable attenuation of US intensity is however noted if US is applied over the temporal bone. The aim of this study was therefore to explore possible changes in the effect of thrombolytic drugs during low-intensity, high-frequency continuous-wave ultrasound (CW-US) exposure.</p> <p>Methods</p> <p>Clots were made from fresh venous blood drawn from healthy volunteers. Each clot was made from 1.4 ml blood and left to coagulate for 1 hour in a plastic test-tube. The thrombolytic drugs used were, 3600 IU streptokinase (SK) or 0.25 U reteplase (r-PA), which were mixed in 160 ml 0.9% NaCl solution. Continuous-wave US exposure was applied at a frequency of 1 MHz and intensities ranging from 0.0125 to 1.2 W/cm<sup>2</sup>. For each thrombolytic drug (n = 2, SK and r-PA) and each intensity (n = 9) interventional clots (US-exposed, n = 6) were submerged in thrombolytic solution and exposed to CW-US while control clots (also submerged in thrombolytic solution, n = 6) were left unexposed to US.</p> <p>To evaluate the effect on clot lysis, the haemoglobin (Hb) released from each clot was measured every 20 min for 1 hour (20, 40 and 60 min). The Hb content (mg) released was estimated by spectrophotometry at 540 nm. The difference in effect on clot lysis was expressed as the difference in the amount of Hb released between pairs of US-exposed clots and control clots. Statistical analysis was performed using Wilcoxon's signed rank test.</p> <p>Results</p> <p>Continuous-wave ultrasound significantly decreased the effects of SK at intensities of 0.9 and 1.2 W/cm<sup>2 </sup>at all times (P < 0.05). Continuous-wave ultrasound significantly increased the effects of r-PA on clot lysis following 20 min exposure at 0.9 W/cm<sup>2 </sup>and at 1.2 W/cm<sup>2</sup>, following 40 min exposure at 0.3, 0.6, 0.9 and at 1.2 W/cm<sup>2</sup>, and following 60 min of exposure at 0.05 0.3, 0.6, 0.9 and at 1.2 W/cm<sup>2 </sup>(all P < 0.05).</p> <p>Conclusion</p> <p>Increasing intensities of CW-US exposure resulted in increased clot lysis of r-PA-treated blood clots, but decreased clot lysis of SK-treated clots.</p> http://www.biomedcentral.com/1471-2261/8/19
collection DOAJ
language English
format Article
sources DOAJ
author Roijer Anders
Carlson Jonas
Härdig Bjarne
spellingShingle Roijer Anders
Carlson Jonas
Härdig Bjarne
Changes in clot lysis levels of reteplase and streptokinase following continuous wave ultrasound exposure, at ultrasound intensities following attenuation from the skull bone
BMC Cardiovascular Disorders
author_facet Roijer Anders
Carlson Jonas
Härdig Bjarne
author_sort Roijer Anders
title Changes in clot lysis levels of reteplase and streptokinase following continuous wave ultrasound exposure, at ultrasound intensities following attenuation from the skull bone
title_short Changes in clot lysis levels of reteplase and streptokinase following continuous wave ultrasound exposure, at ultrasound intensities following attenuation from the skull bone
title_full Changes in clot lysis levels of reteplase and streptokinase following continuous wave ultrasound exposure, at ultrasound intensities following attenuation from the skull bone
title_fullStr Changes in clot lysis levels of reteplase and streptokinase following continuous wave ultrasound exposure, at ultrasound intensities following attenuation from the skull bone
title_full_unstemmed Changes in clot lysis levels of reteplase and streptokinase following continuous wave ultrasound exposure, at ultrasound intensities following attenuation from the skull bone
title_sort changes in clot lysis levels of reteplase and streptokinase following continuous wave ultrasound exposure, at ultrasound intensities following attenuation from the skull bone
publisher BMC
series BMC Cardiovascular Disorders
issn 1471-2261
publishDate 2008-08-01
description <p>Abstract</p> <p>Background</p> <p>Ultrasound (US) has been used to enhance thrombolytic therapy in the treatment of stroke. Considerable attenuation of US intensity is however noted if US is applied over the temporal bone. The aim of this study was therefore to explore possible changes in the effect of thrombolytic drugs during low-intensity, high-frequency continuous-wave ultrasound (CW-US) exposure.</p> <p>Methods</p> <p>Clots were made from fresh venous blood drawn from healthy volunteers. Each clot was made from 1.4 ml blood and left to coagulate for 1 hour in a plastic test-tube. The thrombolytic drugs used were, 3600 IU streptokinase (SK) or 0.25 U reteplase (r-PA), which were mixed in 160 ml 0.9% NaCl solution. Continuous-wave US exposure was applied at a frequency of 1 MHz and intensities ranging from 0.0125 to 1.2 W/cm<sup>2</sup>. For each thrombolytic drug (n = 2, SK and r-PA) and each intensity (n = 9) interventional clots (US-exposed, n = 6) were submerged in thrombolytic solution and exposed to CW-US while control clots (also submerged in thrombolytic solution, n = 6) were left unexposed to US.</p> <p>To evaluate the effect on clot lysis, the haemoglobin (Hb) released from each clot was measured every 20 min for 1 hour (20, 40 and 60 min). The Hb content (mg) released was estimated by spectrophotometry at 540 nm. The difference in effect on clot lysis was expressed as the difference in the amount of Hb released between pairs of US-exposed clots and control clots. Statistical analysis was performed using Wilcoxon's signed rank test.</p> <p>Results</p> <p>Continuous-wave ultrasound significantly decreased the effects of SK at intensities of 0.9 and 1.2 W/cm<sup>2 </sup>at all times (P < 0.05). Continuous-wave ultrasound significantly increased the effects of r-PA on clot lysis following 20 min exposure at 0.9 W/cm<sup>2 </sup>and at 1.2 W/cm<sup>2</sup>, following 40 min exposure at 0.3, 0.6, 0.9 and at 1.2 W/cm<sup>2</sup>, and following 60 min of exposure at 0.05 0.3, 0.6, 0.9 and at 1.2 W/cm<sup>2 </sup>(all P < 0.05).</p> <p>Conclusion</p> <p>Increasing intensities of CW-US exposure resulted in increased clot lysis of r-PA-treated blood clots, but decreased clot lysis of SK-treated clots.</p>
url http://www.biomedcentral.com/1471-2261/8/19
work_keys_str_mv AT roijeranders changesinclotlysislevelsofreteplaseandstreptokinasefollowingcontinuouswaveultrasoundexposureatultrasoundintensitiesfollowingattenuationfromtheskullbone
AT carlsonjonas changesinclotlysislevelsofreteplaseandstreptokinasefollowingcontinuouswaveultrasoundexposureatultrasoundintensitiesfollowingattenuationfromtheskullbone
AT hardigbjarne changesinclotlysislevelsofreteplaseandstreptokinasefollowingcontinuouswaveultrasoundexposureatultrasoundintensitiesfollowingattenuationfromtheskullbone
_version_ 1724646151558266880